Indications and limitations of class I drugs in atrial fibrillation.
Fromer
M A
MA
Centre Universitaire Hospitalier Vaudois, Lausanne, Switzerland.
D000889:Anti-Arrhythmia Agents / Q000009:adverse effects / Q000145:classification / Q000627:therapeutic use*; D001281:Atrial Fibrillation / Q000188:drug therapy*; D002986:Clinical Trials as Topic; D006801:Humans; D016032:Randomized Controlled Trials as Topic
D000889:Anti-Arrhythmia Agents